Patients Coming Off Weight-Loss Jabs Regain Weight at a Quadrupled Rate Compared to Dieters

A recent study indicates that patients who discontinue blockbuster slimming jabs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who stop conventional lifestyle regimens.

Research printed in a prominent health publication shows that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the mass is regained at an estimated rate of nearly a kilo each month once they quit.

"People using such drugs should be informed of the risk of fast weight regain when the treatment concludes," cautioned expert Dr. Susan Jebb.

This pace of regain means a return to pre-treatment mass in about 18 months.

Analyzing Treatments

The research, which reviewed dozens of studies involving thousands of participants, compared the effects of the injectable medications with conventional dieting.

Scientists point out that people who lose weight through lifestyle changes alone typically have a less rapid weight regain—perhaps 100 grams monthly—after stopping.

Explaining the Rapid Rebound

Doctors propose the mechanism of the drugs accounts for the amplified weight return.

The injections copy a body's own chemical called glucagon-like peptide-1, which controls hunger.

"Artificially providing GLP-1 levels far above than the body's typical production might result in the system to produce less of its endogenous GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.

"Stopping of this GLP-1 'fix' means hunger is unsuppressed, making binge eating a significant risk."

An Ongoing Disease?

Health authorities advise the jabs for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.

Professionals argue that, considering the high risk of relapse, the therapy might need to be ongoing.

This view is supported by pharmaceutical companies, who state that the results "underscore the long-term character of obesity," akin to managing diseases like hypertension.

User Accounts

Individuals who have discontinued the medication explain a sudden return of cravings.

"I experienced something flipping and you become extremely hungry," said an individual.

This difficulty is compounded if individuals have not established lasting lifestyle or habit modifications during therapy.

Widespread Adoption

Figures indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.

• Adoption is greater among women than men.
• The middle-aged age group shows the highest level of interest.
• A large proportion obtain the medications through private healthcare rather than the NHS.

In conclusion, clinicians stress that while these medications are powerful agents for shedding pounds, they are not a standalone cure and lasting health benefits hinges on integrated lifestyle changes.